NCT04704388 (COMEBAC) is a clinical trial in Covid19, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT04704388?

NCT04704388 is sponsored by Assistance Publique - Hôpitaux de Paris.

Is NCT04704388 still recruiting?

NCT04704388 is currently completed. Last updated 1 April 2021.

Last reviewed 2021-04-01 · How we verify

NCT04704388: COMEBAC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care

Completed Last updated 1 April 2021

What this trial tests

trial in Covid19 in 478 participants. Completed in 1 October 2020.

Timeline

1 June 2020

Primary endpoint
1 October 2020

1 October 2020

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Completed
Study type	OBSERVATIONAL
Enrollment	478
Start date	1 June 2020
Primary completion	1 October 2020
Estimated completion	1 October 2020
Sites	1 location across France

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the proportion of post-intensive care syndrome (PICS) of patients who received high flow humidified oxygen with FiO2 ≥50% for more than 48h and / or who received mechanical ventilation for more than 48h in a context of hospitalization in intensive care for COVID-19 pneumonia

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome.
Jutant EM, Meyrignac O, Beurnier A, Jaïs X, et al · · 2022 · cited 24× · PMID 35445129 · DOI 10.1183/23120541.00479-2021
Functional respiratory complaints among COVID-19 survivors: a prospective cohort study.
Beurnier A, Savale L, Jaïs X, Colle R, et al · · 2023 · cited 14× · PMID 37131523 · DOI 10.1183/23120541.00063-2023
Proceedings of Reanimation 2021, the French Intensive Care Society International Congress.
· 2021 · cited 4× · PMID 34185186 · DOI 10.1186/s13613-021-00862-0
Four- and sixteen-month clinical status of a cohort of patients following hospitalization for COVID-19.
Pham T, Morin L, Savale L, Colle R, et al · · 2024 · cited 3× · PMID 38843604 · DOI 10.1016/j.resmer.2024.101099

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04704388 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 1 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04704388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing